114 related articles for article (PubMed ID: 15688099)
41. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis.
Mikami T; Yanagisawa N; Baba H; Koike M; Okayasu I
Cancer; 1999 Jan; 85(2):318-25. PubMed ID: 10023698
[TBL] [Abstract][Full Text] [Related]
42. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas.
Yao L; Iwai M; Furuta I
Oral Oncol; 1999 Jan; 35(1):56-62. PubMed ID: 10211311
[TBL] [Abstract][Full Text] [Related]
43. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
Sharma H; Sen S; Mathur M; Bahadur S; Singh N
Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
[TBL] [Abstract][Full Text] [Related]
45. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
[TBL] [Abstract][Full Text] [Related]
46. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression.
Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W
Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732
[TBL] [Abstract][Full Text] [Related]
47. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
48. Significance of p53 and bcl-2 immunoexpression in the prognosis of laryngeal squamous cell carcinoma.
Yildirim S; Cermik H; Işitmangil T; Baloglu H; Gungor A; Pekkafali Z
J Int Med Res; 2002; 30(6):597-600. PubMed ID: 12526287
[TBL] [Abstract][Full Text] [Related]
49. Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer.
Shibata Y; Hidaka S; Tagawa Y; Nagayasu T
Anticancer Res; 2004; 24(3b):1925-8. PubMed ID: 15274378
[TBL] [Abstract][Full Text] [Related]
50. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Torzewski M; Sarbia M; Heep H; Dutkowski P; Willers R; Gabbert HE
Clin Cancer Res; 1998 Mar; 4(3):577-83. PubMed ID: 9533524
[TBL] [Abstract][Full Text] [Related]
51. [The expression of bcl-2, P53 and c-erbB-2 onco-proteins in breast cancer and their clinicopathological significance].
Gao L; Ding H; Deng Y
Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):165-8. PubMed ID: 9275673
[TBL] [Abstract][Full Text] [Related]
52. Bcl-Xl protein expression in laryngeal squamous cell carcinoma.
Krecicki T; Fraczek M; Kozlak J; Zatonski T; Jelen M; Dus D
Clin Otolaryngol Allied Sci; 2004 Feb; 29(1):55-8. PubMed ID: 14961853
[TBL] [Abstract][Full Text] [Related]
53. Clinical relevance of p53 and bcl-2 protein over-expression in laryngeal squamous-cell carcinoma.
Pruneri G; Pignataro L; Carboni N; Ronchetti D; Cesana BM; Ottaviani A; Neri A; Buffa R
Int J Cancer; 1998 Jun; 79(3):263-8. PubMed ID: 9645348
[TBL] [Abstract][Full Text] [Related]
54. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
55. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
56. Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients.
Fleming MV; Guinee DG; Chu WS; Freedman AN; Caporaso NE; Bennett WP; Colby TV; Tazelaar H; Abbondanzo SL; Jett J; Pairolero P; Trastek V; Liotta LA; Harris CC; Travis WD
Hum Pathol; 1998 Jan; 29(1):60-4. PubMed ID: 9445135
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of apoptosis markers in conjunctival and eyelid benign and malignant tumors.
Reszec J; Sulkowska M; Kanczuga-Koda L; Janica J; Skawronska M; Pepinski W; Sulkowski S
Ann N Y Acad Sci; 2003 Dec; 1010():748-51. PubMed ID: 15033822
[TBL] [Abstract][Full Text] [Related]
58. An immunohistochemical study of bcl-2 and p53 protein expression in pancreatic carcinomas.
Ohshio G; Suwa H; Imamura T; Yamaki K; Tanaka T; Hashimoto Y; Imamura M
Scand J Gastroenterol; 1998 May; 33(5):535-9. PubMed ID: 9648995
[TBL] [Abstract][Full Text] [Related]
59. [Expression of P33ING1, P53 and their relationship with apoptosis in anal canal carcinoma].
Chen LS; Li TY; Cao YF; Liang JL; Zhang S; Tang WZ; Tang ZJ; Gao F
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):338-41. PubMed ID: 16886119
[TBL] [Abstract][Full Text] [Related]
60. Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas: differences between keratinizing and nonkeratinizing types.
Ohbu M; Saegusa M; Okayasu I
Virchows Arch; 1995; 427(3):271-6. PubMed ID: 7496596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
